174 related articles for article (PubMed ID: 12180480)
1. Flutamide-induced acute renal failure in a patient with metastatic prostate cancer.
Altiparmak MR; Bilici A; Kisacik B; Ozguroglu M
Med Oncol; 2002; 19(2):117-9. PubMed ID: 12180480
[TBL] [Abstract][Full Text] [Related]
2. [A case of fulminant hepatitis caused by antiandrogen, flutamide in a patient with prostate cancer].
Satoh T; Egawa S; Katsuta M; Iwamura M; Uchida T; Koshiba K
Nihon Hinyokika Gakkai Zasshi; 1997 Jul; 88(7):694-6. PubMed ID: 9267134
[TBL] [Abstract][Full Text] [Related]
3. Bilateral orchiectomy with or without flutamide for metastatic prostate cancer.
Eisenberger MA; Blumenstein BA; Crawford ED; Miller G; McLeod DG; Loehrer PJ; Wilding G; Sears K; Culkin DJ; Thompson IM; Bueschen AJ; Lowe BA
N Engl J Med; 1998 Oct; 339(15):1036-42. PubMed ID: 9761805
[TBL] [Abstract][Full Text] [Related]
4. Bicalutamide: a new antiandrogen for use in combination with castration for patients with advanced prostate cancer.
Blackledge G; Kolvenbag G; Nash A
Anticancer Drugs; 1996 Jan; 7(1):27-34. PubMed ID: 8742095
[TBL] [Abstract][Full Text] [Related]
5. Flutamide photosensitivity.
Leroy D; Dompmartin A; Szczurko C
Photodermatol Photoimmunol Photomed; 1996 Oct; 12(5):216-8. PubMed ID: 9112281
[TBL] [Abstract][Full Text] [Related]
6. Flutamide versus orchidectomy in the treatment of metastatic prostate carcinoma.
Boccon-Gibod L; Fournier G; Bottet P; Marechal JM; Guiter J; Rischman P; Hubert J; Soret JY; Mangin P; Mallo C; Fraysse CE
Eur Urol; 1997; 32(4):391-5; discussion 395-6. PubMed ID: 9412794
[TBL] [Abstract][Full Text] [Related]
7. Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer.
Scher HI; Kelly WK
J Clin Oncol; 1993 Aug; 11(8):1566-72. PubMed ID: 7687666
[TBL] [Abstract][Full Text] [Related]
8. [Anti-androgen withdrawal syndrome].
Breul J; Paul R
Urologe A; 1998 Mar; 37(2):156-8. PubMed ID: 9563126
[TBL] [Abstract][Full Text] [Related]
9. Long-term effectiveness of luteinizing hormone-releasing hormone agonist or antiandrogen monotherapy in elderly men with localized prostate cancer (T1-2): a retrospective study.
Raina R; Pahalajani G; Agarwal A; Zippe C
Asian J Androl; 2007 Mar; 9(2):253-8. PubMed ID: 17334592
[TBL] [Abstract][Full Text] [Related]
10. Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients.
Gomez JL; Dupont A; Cusan L; Tremblay M; Suburu R; Lemay M; Labrie F
Am J Med; 1992 May; 92(5):465-70. PubMed ID: 1349790
[TBL] [Abstract][Full Text] [Related]
11. Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.
Suzuki H; Okihara K; Miyake H; Fujisawa M; Miyoshi S; Matsumoto T; Fujii M; Takihana Y; Usui T; Matsuda T; Ozono S; Kumon H; Ichikawa T; Miki T;
J Urol; 2008 Sep; 180(3):921-7. PubMed ID: 18635218
[TBL] [Abstract][Full Text] [Related]
12. [Changes in liver function induced by flutamide in patients with prostate cancer (studies in patients treated with total androgen blockage)].
Ikemoto I; Ohishi Y; Yamazaki H; Wada T; Aizawa Y
Nihon Hinyokika Gakkai Zasshi; 2000 Jun; 91(6):556-61. PubMed ID: 10897581
[TBL] [Abstract][Full Text] [Related]
13. Antiandrogen-associated hepatotoxicity in the management of advanced prostate cancer.
Lin AD; Chen KK; Lin AT; Chang YH; Wu HH; Kuo JY; Huang WJ; Hsu YS; Chung HJ; Chang LS
J Chin Med Assoc; 2003 Dec; 66(12):735-40. PubMed ID: 15015823
[TBL] [Abstract][Full Text] [Related]
14. [Antiandrogen in prostate cancer].
Maeda O; Usami M
Nihon Rinsho; 2002 Dec; 60 Suppl 11():188-92. PubMed ID: 12599569
[No Abstract] [Full Text] [Related]
15. Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol.
Chang A; Yeap B; Davis T; Blum R; Hahn R; Khanna O; Fisher H; Rosenthal J; Witte R; Schinella R; Trump D
J Clin Oncol; 1996 Aug; 14(8):2250-7. PubMed ID: 8708714
[TBL] [Abstract][Full Text] [Related]
16. The use of flutamide as a single antiandrogen treatment for hormone-refractory prostate cancer.
Pitts WR
BJU Int; 2004 May; 93(7):1119-20. PubMed ID: 15142186
[No Abstract] [Full Text] [Related]
17. [Liver failure caused by flutamide].
Guzmán Martínez-Valls PL; Ferrero Doria R; Morga Egea JP; Tomás Ros M; Rico Galiano JL; Sempere Gutiérrez A; Gil Franco J; Fontana Compiano LO
Actas Urol Esp; 1997 Mar; 21(3):278-82. PubMed ID: 9324896
[TBL] [Abstract][Full Text] [Related]
18. Flutamide-associated acute liver failure.
Famularo G; De Simone C; Minisola G; Nicotra GC
Ann Ital Med Int; 2003; 18(4):250-3. PubMed ID: 14971714
[TBL] [Abstract][Full Text] [Related]
19. Nilutamide: an antiandrogen for the treatment of prostate cancer.
Dole EJ; Holdsworth MT
Ann Pharmacother; 1997 Jan; 31(1):65-75. PubMed ID: 8997470
[TBL] [Abstract][Full Text] [Related]
20. Serum luteinizing hormone (LH) biological activity in castrated patients with cancer of the prostate receiving a pure antiandrogen and in estrogen-pretreated patients treated with an LH-releasing hormone agonist and antiandrogen.
St Arnaud R; Lachance R; Dupont A; Labrie F
J Clin Endocrinol Metab; 1986 Aug; 63(2):297-302. PubMed ID: 3522618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
